Gabapentin Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gabapentin Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Gabapentin Drug market is segmented into
Capsule
Tablet
Oral Solution
Segment by Application, the Gabapentin Drug market is segmented into
Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others
Regional and Country-level Analysis
The Gabapentin Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gabapentin Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gabapentin Drug Market Share Analysis
Gabapentin Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gabapentin Drug business, the date to enter into the Gabapentin Drug market, Gabapentin Drug product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
1 Study Coverage
1.1 Gabapentin Drug Product Introduction
1.2 Market Segments
1.3 Key Gabapentin Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gabapentin Drug Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.4.4 Oral Solution
1.5 Market by Application
1.5.1 Global Gabapentin Drug Market Size Growth Rate by Application
1.5.2 Postherpetic Neuralgia in Adults
1.5.3 Partial Onset Seizures
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gabapentin Drug Market Size, Estimates and Forecasts
2.1.1 Global Gabapentin Drug Revenue 2015-2026
2.1.2 Global Gabapentin Drug Sales 2015-2026
2.2 Global Gabapentin Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gabapentin Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Gabapentin Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gabapentin Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gabapentin Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gabapentin Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Gabapentin Drug Revenue Forecast by Region (2021-2026)
3 Global Gabapentin Drug Competitor Landscape by Players
3.1 Global Top Gabapentin Drug Sales by Manufacturers
3.1.1 Global Gabapentin Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Gabapentin Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gabapentin Drug Manufacturers by Revenue
3.2.1 Global Gabapentin Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Gabapentin Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gabapentin Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gabapentin Drug Revenue in 2019
3.2.5 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gabapentin Drug Price by Manufacturers
3.4 Global Gabapentin Drug Manufacturing Base Distribution, Product Types
3.4.1 Gabapentin Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gabapentin Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gabapentin Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gabapentin Drug Market Size by Type (2015-2020)
4.1.1 Global Gabapentin Drug Sales by Type (2015-2020)
4.1.2 Global Gabapentin Drug Revenue by Type (2015-2020)
4.1.3 Gabapentin Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gabapentin Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Gabapentin Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Gabapentin Drug Revenue Forecast by Type (2021-2026)
4.2.3 Gabapentin Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gabapentin Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gabapentin Drug Market Size by Application (2015-2020)
5.1.1 Global Gabapentin Drug Sales by Application (2015-2020)
5.1.2 Global Gabapentin Drug Revenue by Application (2015-2020)
5.1.3 Gabapentin Drug Price by Application (2015-2020)
5.2 Gabapentin Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Gabapentin Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Gabapentin Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Gabapentin Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Gabapentin Drug Market Size YoY Growth 2015-2026
6.1.1 United States Gabapentin Drug Sales YoY Growth 2015-2026
6.1.2 United States Gabapentin Drug Revenue YoY Growth 2015-2026
6.1.3 United States Gabapentin Drug Market Share in Global Market 2015-2026
6.2 United States Gabapentin Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Gabapentin Drug Players by Sales (2015-2020)
6.2.2 United States Top Gabapentin Drug Players by Revenue (2015-2020)
6.3 United States Gabapentin Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Gabapentin Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Gabapentin Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Gabapentin Drug Price by Type (2015-2020)
6.4 United States Gabapentin Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Gabapentin Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Gabapentin Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Gabapentin Drug Price Forecast by Type (2021-2026)
6.5 United States Gabapentin Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Gabapentin Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Gabapentin Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Gabapentin Drug Price by Application (2015-2020)
6.6 United States Gabapentin Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Gabapentin Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Gabapentin Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Gabapentin Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gabapentin Drug Market Size YoY Growth 2015-2026
7.2 North America Gabapentin Drug Market Facts & Figures by Country
7.2.1 North America Gabapentin Drug Sales by Country (2015-2020)
7.2.2 North America Gabapentin Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gabapentin Drug Market Size YoY Growth 2015-2026
8.2 Europe Gabapentin Drug Market Facts & Figures by Country
8.2.1 Europe Gabapentin Drug Sales by Country
8.2.2 Europe Gabapentin Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gabapentin Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gabapentin Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Gabapentin Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Gabapentin Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gabapentin Drug Market Size YoY Growth 2015-2026
10.2 Latin America Gabapentin Drug Market Facts & Figures by Country
10.2.1 Latin America Gabapentin Drug Sales by Country
10.2.2 Latin America Gabapentin Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gabapentin Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gabapentin Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Gabapentin Drug Sales by Country
11.2.2 Middle East and Africa Gabapentin Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Gabapentin Drug Products Offered
12.1.5 Pfizer Recent Development
12.2 Depomed
12.2.1 Depomed Corporation Information
12.2.2 Depomed Description and Business Overview
12.2.3 Depomed Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Depomed Gabapentin Drug Products Offered
12.2.5 Depomed Recent Development
12.3 Apotex
12.3.1 Apotex Corporation Information
12.3.2 Apotex Description and Business Overview
12.3.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Apotex Gabapentin Drug Products Offered
12.3.5 Apotex Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Description and Business Overview
12.4.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teva Gabapentin Drug Products Offered
12.4.5 Teva Recent Development
12.5 Acella Pharmaceuticals
12.5.1 Acella Pharmaceuticals Corporation Information
12.5.2 Acella Pharmaceuticals Description and Business Overview
12.5.3 Acella Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Acella Pharmaceuticals Gabapentin Drug Products Offered
12.5.5 Acella Pharmaceuticals Recent Development
12.6 Taro
12.6.1 Taro Corporation Information
12.6.2 Taro Description and Business Overview
12.6.3 Taro Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Taro Gabapentin Drug Products Offered
12.6.5 Taro Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Corporation Information
12.7.2 Sun Pharmaceutical Description and Business Overview
12.7.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sun Pharmaceutical Gabapentin Drug Products Offered
12.7.5 Sun Pharmaceutical Recent Development
12.8 Glenmark
12.8.1 Glenmark Corporation Information
12.8.2 Glenmark Description and Business Overview
12.8.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Glenmark Gabapentin Drug Products Offered
12.8.5 Glenmark Recent Development
12.9 Amneal Pharmaceuticals
12.9.1 Amneal Pharmaceuticals Corporation Information
12.9.2 Amneal Pharmaceuticals Description and Business Overview
12.9.3 Amneal Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Amneal Pharmaceuticals Gabapentin Drug Products Offered
12.9.5 Amneal Pharmaceuticals Recent Development
12.10 Aurobindo Pharma
12.10.1 Aurobindo Pharma Corporation Information
12.10.2 Aurobindo Pharma Description and Business Overview
12.10.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Aurobindo Pharma Gabapentin Drug Products Offered
12.10.5 Aurobindo Pharma Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Gabapentin Drug Products Offered
12.11.5 Pfizer Recent Development
12.12 Hi-Tech Pharmaceuticals
12.12.1 Hi-Tech Pharmaceuticals Corporation Information
12.12.2 Hi-Tech Pharmaceuticals Description and Business Overview
12.12.3 Hi-Tech Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hi-Tech Pharmaceuticals Products Offered
12.12.5 Hi-Tech Pharmaceuticals Recent Development
12.13 Marksans Pharma
12.13.1 Marksans Pharma Corporation Information
12.13.2 Marksans Pharma Description and Business Overview
12.13.3 Marksans Pharma Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Marksans Pharma Products Offered
12.13.5 Marksans Pharma Recent Development
12.14 Mylan
12.14.1 Mylan Corporation Information
12.14.2 Mylan Description and Business Overview
12.14.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Mylan Products Offered
12.14.5 Mylan Recent Development
12.15 InvaGen Pharmaceuticals
12.15.1 InvaGen Pharmaceuticals Corporation Information
12.15.2 InvaGen Pharmaceuticals Description and Business Overview
12.15.3 InvaGen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.15.4 InvaGen Pharmaceuticals Products Offered
12.15.5 InvaGen Pharmaceuticals Recent Development
12.16 Alkem Laboratories
12.16.1 Alkem Laboratories Corporation Information
12.16.2 Alkem Laboratories Description and Business Overview
12.16.3 Alkem Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Alkem Laboratories Products Offered
12.16.5 Alkem Laboratories Recent Development
12.17 Tris Pharma
12.17.1 Tris Pharma Corporation Information
12.17.2 Tris Pharma Description and Business Overview
12.17.3 Tris Pharma Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Tris Pharma Products Offered
12.17.5 Tris Pharma Recent Development
12.18 ACI HealthCare Limited
12.18.1 ACI HealthCare Limited Corporation Information
12.18.2 ACI HealthCare Limited Description and Business Overview
12.18.3 ACI HealthCare Limited Sales, Revenue and Gross Margin (2015-2020)
12.18.4 ACI HealthCare Limited Products Offered
12.18.5 ACI HealthCare Limited Recent Development
12.19 Jiangsu Hengrui Medicine
12.19.1 Jiangsu Hengrui Medicine Corporation Information
12.19.2 Jiangsu Hengrui Medicine Description and Business Overview
12.19.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Jiangsu Hengrui Medicine Products Offered
12.19.5 Jiangsu Hengrui Medicine Recent Development
12.20 CSPC Ouyi Pharmaceutical
12.20.1 CSPC Ouyi Pharmaceutical Corporation Information
12.20.2 CSPC Ouyi Pharmaceutical Description and Business Overview
12.20.3 CSPC Ouyi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.20.4 CSPC Ouyi Pharmaceutical Products Offered
12.20.5 CSPC Ouyi Pharmaceutical Recent Development
12.21 Sciegen Pharmaceuticals
12.21.1 Sciegen Pharmaceuticals Corporation Information
12.21.2 Sciegen Pharmaceuticals Description and Business Overview
12.21.3 Sciegen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Sciegen Pharmaceuticals Products Offered
12.21.5 Sciegen Pharmaceuticals Recent Development
12.22 Epic Pharma
12.22.1 Epic Pharma Corporation Information
12.22.2 Epic Pharma Description and Business Overview
12.22.3 Epic Pharma Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Epic Pharma Products Offered
12.22.5 Epic Pharma Recent Development
12.23 Lupin Limited
12.23.1 Lupin Limited Corporation Information
12.23.2 Lupin Limited Description and Business Overview
12.23.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Lupin Limited Products Offered
12.23.5 Lupin Limited Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gabapentin Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gabapentin Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
*If Applicable.